Immunohistochemical detection of phosphorylated JAK-2 and STAT-5 proteins and correlation with erythropoietin receptor (EpoR) expression status in human brain tumors

Journal of Neuro-Oncology

Volumn 100, Issue 2, 2010, Pages 157-164

  Kondyli, M ^a   Gatzounis, G ^b   Kyritsis, A ^c   Varakis, J ^a   Assimakopoulou, M ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

EpoR; Human brain tumors; pJAK 2; pSTAT 5

Indexed keywords

ERYTHROPOIETIN RECEPTOR; JANUS KINASE 2; STAT5 PROTEIN;

ADULT; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; EPENDYMOMA; FEMALE; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MENINGIOMA; OLIGODENDROGLIOMA; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; JANUS KINASE 2; MIDDLE AGED; PHOSPHORYLATION; RECEPTORS, ERYTHROPOIETIN; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; YOUNG ADULT;

EID: 79952189114     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0156-2     Document Type: Article

References (61)

1. Yamaoka K, Saharinen P, Pesu M, Holt VET, Silvennoinen O, O'Shea JJ (2004) The Janus kinases (Jaks). Genome Biol 5:253-256
2. Shual K, Ziemiecki A, Wilks AF, Harpur AG, Sadowski HB, Gilman MZ, Darnell JE (1993) Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 366:580-583 (Pubitemid 24036000)
3. Horvath CM (2000) STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 25(10):496-502
4. De-Fraja C, Conti L, Magrassi L, Govoni S, Cattaneo E (1998) Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain. J Neurosci Res 54:320-330 (Pubitemid 28493942)
5. Bonni A, Sun Y, Nadal-Vicens M, Bhatt A, Frank DA, Rozovsky I, Stahl N, Yancopoulos GD, Greenberg ME (1997) Regulation of gliogenesis in the Central Nervous System by the JAK-STAT signaling pathway. Science 278:477-483 (Pubitemid 27454434)
6. Hei F, Ge W, Martinowich K, Becker-Catania S, Coskun V, Zhu W, Wu H, Castro D, Guillemot F, Fan G, de Vellis J, Sun Y (2005) A positive autoregulatory loop of JAK-STAT signaling controls the onset of astrogliogenesis. Nat Neurosci 8:616-625 (Pubitemid 40594203)
7. Sriram K, Benkovic SA, Hebert MA, Miller DB, O'Callaghan JP (2004) Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of neurodegeneration. J Biol Chem 279(19):19936-19947
8. Bromberg J (2002) Stat proteins and oncogenesis. J Clin Invest 109:1139-1142
9. Buettner R, Mora LB, Jove R (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8(4):945-954 (Pubitemid 35177340)
10. Chong ZZ, Kang JQ, Maiese K (2002) Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Blood Flow Metab 22(5):503-514 (Pubitemid 34477771)
11. Buemi M, Cavallaro E, Floccari F, Sturiale A, Aloisi C, Trimarchi M, Corica F, Frisina N (2003) The pleiotropic effects of erythropoietin in the Central Nervous System. J Neuropathol Exp Neurol 62(3):228-236 (Pubitemid 36330674)
12. Sugawa M, Sakurai Y, Ishikawa-Ieda Y, Suzuki H, Asou H (2002) Effects of erythropoietin on glial cell-development; oligodendrocyte maturation and astrocyte proliferation. Neurosci Res 44(4):391-403 (Pubitemid 35341813)
13. Lee SM, Nguyen TH, Park MH, Kim KS, Cho KJ, Moon DC, Kim HY, Yon DY, Hong JT (2004) EPO receptor-mediated ERK kinase and NF-kappaB activation in erythropoietin-promoted differentiation of astrocytes. Biochem Biophys Res Commun 320(4):1087-1095
14. Park MH, Lee SM, Lee JW, Son DJ, Moon DC, Yoon DY, Hong JT (2006) ERK-mediated production of neuroprophic factors by astrocytes promotes neuronal stem cell differentiation by erythropoietin. Biochem Biophys Res Commun 339(4):1021-1028 (Pubitemid 41790566)
15. Digicaylioglu M, Lipton SA (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signaling cascades. Nature 412:641-647 (Pubitemid 32772276)
16. Dawson TM (2002) Preconditioning-mediated neuroprotection through erythropoietin? Lancet 359:96-97
17. Juul S (2002) Erythropoietin in the Central Nervous System, and its use to prevent hypoxic-ischemic brain damage. Acta Paediatr Suppl 438:36-42
18. Kilic U, Kilic E, Soliz J, Bassetti CL, Gassmann M, Hermann DM (2005) Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. Faseb J 19(2):249-251 (Pubitemid 40189271)
19. Mulcahy L (2001) The erythropoietin receptor. Semin Oncol 28(suppl 8):19-23
20. Farrell F, Lee A (2004) The erythropoietin receptor and its expression in tumor cells and other tissues. Oncol 9:18-30 (Pubitemid 39658342)
21. Hardee ME, Arcasoy MO, Blackwell KL, Kirkpatrick JP, Dewhirst MW (2006) Erythropoietin biology in cancer. Clin Cancer Res 12:332-339 (Pubitemid 43166118)
22. Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, Wells A, Ferris RL, Grandis JR (2005) Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene 24(27):4442-4449 (Pubitemid 40961767)
23. Mohyeldin A, Lu H, Dalgard C, Lai SY, Cohen N, Acs G, Verma A (2005) Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. Neoplasia 7(5):537-543 (Pubitemid 40791872)
24. Mohyeldin A, Dalgard CL, Lu H, Mcfate T, Tait AS, Patel VC, Wong K, Rushing E, Roy S, Acs G, Verma A (2007) Survival and invasiveness of astrocytomas promoted by erythropoietin. J Neurosurg 106(2):338-350 (Pubitemid 46203166)
25. Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell'Era P, Nico B, Roncali L, Dammacco F (1999) Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93:2627-2636 (Pubitemid 29181195)
26. Leyland-Jones B (2002) Evidence for erythropoietin as a molecular targeting agent. Semin Oncol 29(3 Suppl 11):145-154
27. Batra S, Perelman N, Luck LR, Shimada H, Malik P (2003) Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab Invest 83:1477-1487 (Pubitemid 37267831)
28. Mittelbronn M, Capper D, Bunz B, Dietz K, Goeppert B, Ajaaj R, Tabatabai G, Stubenvol F, Schlaszus H, Merseburger AS, Becker R, Freudenstein D, Wick W, Weller M, Meyermann R, Simon P (2007) De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival. Neuropathol Appl Neurobiol 33(3):299-307 (Pubitemid 46701048)
29. Küster O, Simon P, Mittelbronn M, Tabatabai G, Hermann C, Strik H, Dietz K, Roser F, Meyermann R, Schittenhelm J (2009) Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumor recurrence. Neuropathol Appl Neurobiol 35(6):555-565
30. Kleihues P, Cavenee WK (2000) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon
31. Acs G, Zhang PJ, Rebbeck TR, Acs P, Verma A (2002) Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer 95:969-981 (Pubitemid 34925345)
32. Neilson LM, Zhu J, Xie J, Malabarba MG, Sakamoto K, Wagner K-U, Kirken RA, Rui H (2007) Coactivation of Jak1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and Stat3 and enhancement of Akt and Stat5a/b pathways. Mol Endocrinol 21(9):2218-2232 (Pubitemid 47347383)
33. Nevalainen MT, Torhorst JXJ, Bubendorf L, Kononen PHJ, Sauter G, Rui H (2004) Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol 22(11):2053-2060 (Pubitemid 41095137)
34. Altman DG (1991) Practical statistics for medical research. Chapman and Hall, London
35. Batistatou A, Stefanou D, Goussia A, Arkoumani E, Papavassiliou A, Agnantis NJ (2004) Estrogen receptor beta (ERβ) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm. J Cancer Res Clin Oncol 130:404-410
36. Kudo A, Fukushima H, Kawakami H, Matsuda M, Goya T, Hirano H (1996) Use of serial semithin frozen sections to evaluate the co-localization of estrogen receptors and progesterone receptors in cells of breast cancer tissues. J Histochem Cytochem 44(6):615-620 (Pubitemid 26177352)
37. Cattaneo E, Magrassi L, De-Fraja C, Conti L, Di Gennaro I, Butti G, Gonovi S (1998) Variations in the levels of the JAK/STAT and ShcA proteins in human brain tumors. Anticancer Res 18(4):2381-2387 (Pubitemid 28386524)
38. Magrassi L, De-Fraja C, Conti L, Butti G, Infuso L, Govoni S, Cattaneo E (1999) Expression of the JAK and STAT superfamilies in human meningiomas. J Neurosurg 91(3):440-446 (Pubitemid 29404436)
39. Meier C, Hoeller S, Bourgau C, Hirschmann P, Schwaller J, Went P, Pileri SA, Reiter A, Dirnhofer S, Tzankov A (2009) Recurrent numerical aberrations of JAK2 and deregulation of the JAK-STAT cascade in lymphomas. Mod Pathol 22(3):476-487
40. Xi S, Zhang Q, Gooding WE, Smithgall TE, Grandis JR (2003) Constitutive activation of Stat5b contributes to carcinogenesis in vivo. Cancer Res 63:6763-6771 (Pubitemid 37322957)
41. Knoops L, Hornakova T, Royer Y, Constantinescu SN, Renauld JC (2008) JAK kinases overexpression promotes in vitro cell transformation. Oncogene 27(11):1511-1519 (Pubitemid 351347883)
42. Karcher S, Steiner HH, Ahmadi R, Zoubaa S, Vasvari G, Bauer H, Unterberg A, Herold-Mende C (2006) Different angiogenic phenotypes in primary and secondary glioblastomas. Int J Cancer 118(9):2182-2189
43. Quesnelle KM, Boehm AL, Grandis JR (2007) STAT-mediated EGFR signaling in cancer. J Cell Biochem 102(2):211-219
44. Ferletta M, Uhrbom L, Olofsson T, Pontén F, Westermark B (2007) Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B induced gliomagenesis. Mol Cancer Res 5:891-897 (Pubitemid 47416666)
45. Ehrenreich H, Hasselblatt M, Knerlich F, von Ahsen N, Jacob S, Sperling S, Woldt H, Vehmeyer K, Nave KA, Sirén AL (2005) A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci U S A 102(3):862-867 (Pubitemid 40282756)
46. Klein M, Hempstead BL, Teng KK (2005) Activation of STAT5-dependent transcription by the neurotrophin receptor Trk. J Neurobiol 63:159-171 (Pubitemid 40525315)
47. Hayakawa F, Naoe T (2006) SFK-STAT pathway: an alternative and important way to malignancies. Ann NY Acad Sci 1086:213-222 (Pubitemid 47084370)
48. Paukku K, Valgeirsdóttir S, Saharinen P, Bergman M, Heldin CH, Silvennoinen O (2000) Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases. Biochem J 345:759-766 (Pubitemid 30099109)
49. Zhang S, Fukuda S, Lee Y, Hangoc G, Cooper S, Spolski R, Leonard WJ, Broxmeyer HE (2000) Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling. J Exp Med 192(5):719-728
50. Storz P, Doppler H, Pfizenmaier K, Muller G (1999) Insulin selectively activates STAT5b, but not STAT5a, via a JAK2-independent signalling pathway in kym-1 rhabdomyosarcoma cells. FEBS Lett 464(3):159-163 (Pubitemid 30017934)
51. Wallace TA, VonDerLinden D, He K, Frank SJ, Sayeski P (2004) Microarray analyses identify JAK2 tyrosine kinase as a key mediator of ligand-independent gene expression. Am J Physiol Cell Physiol 287:981-991
52. Lobie PE, Ronsin B, Silvennoinen O, Haldosén L-A, Norstedt G, Morel G (1996) Constitutive nuclear localization of Janus Kinases 1 and 2. Endocrinology 137:4037-4045 (Pubitemid 26284681)
53. Ram PA, Waxman DJ (1997) Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J Biol Chem 272:17694-17702 (Pubitemid 27311207)
54. Sorenson RL, Stout LE (1995) Prolactin receptors and JAK2 in islets of Langerhans: an immunohistochemical analysis. Endocrinology 136:4092-4098
55. Royer Y, Staerk Y, Costuleanu M, Courtoy PJ, Constantinescu SN (2005) Janus kinases affect thrombopoietin receptor cell surface localization and stability. J Biol Chem 280:27251-27261 (Pubitemid 41040765)
56. Nilsson J, Bjursell G, Kannius-Janson M (2006) Nuclear JAK2 and transcription factor NF1-C2: a novel mechanism of prolactin signaling in mammary epithelial cells. Mol Cell Biol 26:5663-5674 (Pubitemid 44134324)
57. Sciaccaluga M, Gianfranceschi GL, Rocco S, Germano G, Roti G, Gorello P, La Starza R, Castigli E (2007) Constitutive phosphorylation of Janus kinse 2 in the GL15 glioblastoma derived human cell line. Oncol Rep 17(1):17-23
58. Yang X, Qiao D, Meyer K, Friedl A (2009) Signal transducers and activators of transcription mediate fibroblast growth factor-induced vascular endothelial morphogenesis. Cancer Res 69(4):1668-1677
59. Alvarez Arroyo MV, Castilla MA, Gonzalez Pacheco FR, Tan D, Riesco A, Casado S, Caramelo C (1998) Role of vascular endothelial growth factor on erythropoietin-related endothelial cell proliferation. J Am Soc Nephrol 9:1998-2004 (Pubitemid 28482147)
60. Semenza GL, Agani F, Iyer N, Kotch L, Laughner E, Leung S, Yu A (1999) Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. Ann N Y Acad Sci 874:262-268 (Pubitemid 29351947)
61. Dudley AC, Thomas D, Best J, Jenkins A (2005) A VEGF/JAK2/STAT5 axis may partially mediate endothelial cell tolerance to hypoxia. Biochem J 390(Pt 2):427-436 (Pubitemid 41337104)